Abdominal Obesity Metabolic Syndrome News - LARVOL Sigma

Abdominal Obesity Metabolic Syndrome

Welcome, Profile Billing Logout

56 Mechanisms of Action

«1 2...5 6 7 8 9 10 11 12 13 141516 17 »

||||||||||  aripiprazole / Generic mfg., amisulpride / Generic mfg.
Enrollment change:  Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome (clinicaltrials.gov) -  Jan 1, 2013
P=N/A, N=132, Completed,  Sponsor: National Taiwan University Hospital
N=400 --> 132

||||||||||  aripiprazole / Generic mfg., amisulpride / Generic mfg.
Trial completion:  Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome (clinicaltrials.gov) -  Jan 1, 2013
P=N/A, N=132, Completed,  Sponsor: National Taiwan University Hospital
N=400 --> 132 Suspended --> Completed

|||||||||| New P3 trial: White Fish for Cardiovascular Risk Factors in Patients With Metabolic Syndrome: the WISH-CARE Study (clinicaltrials.gov) - Dec 30, 2012
P3, N=273, Completed, Sponsor: Hospital Universitario Ramon y Cajal

|||||||||| New P1 trial: The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome (clinicaltrials.gov) - Dec 18, 2012
P1, N=45, Recruiting, Sponsor: University of Connecticut

|||||||||| Trial completion: Health Effects of Recreational Soccer in Type 2 Diabetic Men (clinicaltrials.gov) - Dec 5, 2012
P=N/A, N=22, Completed, Sponsor: University of Copenhagen
Suspended --> Completed Active, not recruiting --> Completed

|||||||||| Clinical: HyTe-2: Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement (clinicaltrials.gov) - Dec 4, 2012
P=N/A, N=155, Active, not recruiting, Sponsor: Coxa, Hospital for Joint Replacement

|||||||||| Enrollment change: Evaluation of Low Source of Signal in SCOUT DS (clinicaltrials.gov) - Dec 2, 2012
P=N/A, N=196, Completed, Sponsor: VeraLight, Inc.
Active, not recruiting --> Completed N=300 --> 196

|||||||||| Trial completion: Etherpaths: Effects of Dietary Polyphenols and ?-3 Fatty Acids on Cardiovascular Risk Factors in High Risk Subjects (clinicaltrials.gov) - Dec 2, 2012
P=N/A, N=86, Completed, Sponsor: Federico II University
N=300 --> 196 Recruiting --> Completed

|||||||||| Enrollment closed: Behavioral Factors in Coronary Heart Disease (clinicaltrials.gov) - Nov 29, 2012
P=N/A, N=694, Active, not recruiting, Sponsor: Duke University
Recruiting --> Completed Completed --> Active, not recruiting

|||||||||| Enrollment change: BOLD-X: Beef in an Optimal Lean Diet (BOLD) Effects on Metabolic Syndrome (clinicaltrials.gov) - Nov 28, 2012
P=N/A, N=63, Completed, Sponsor: Penn State University
Completed --> Active, not recruiting N=90 --> 63

|||||||||| Enrollment change: Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant (clinicaltrials.gov) - Nov 28, 2012
P=N/A, N=244, Completed, Sponsor: Fred Hutchinson Cancer Research Center
N=90 --> 63 N=386 --> 244

|||||||||| Enrollment change: Examining the Relationship Between Tobacco Exposure, Abdominal Obesity, and Metabolic Syndrome in Adolescents (The STRONG Kids Study) (clinicaltrials.gov) - Nov 28, 2012
P=N/A, N=117, Completed, Sponsor: University of Rochester
N=386 --> 244 N=240 --> 117

|||||||||| Trial completion: BOLD-X: Beef in an Optimal Lean Diet (BOLD) Effects on Metabolic Syndrome (clinicaltrials.gov) - Nov 28, 2012
P=N/A, N=63, Completed, Sponsor: Penn State University
N=240 --> 117 Active, not recruiting --> Completed

|||||||||| Trial completion: Grains Reduce Adiposity and Improve Nutrition Study (clinicaltrials.gov) - Nov 28, 2012
P=N/A, N=54, Completed, Sponsor: Penn State University
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant (clinicaltrials.gov) - Nov 28, 2012
P=N/A, N=244, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Examining the Relationship Between Tobacco Exposure, Abdominal Obesity, and Metabolic Syndrome in Adolescents (The STRONG Kids Study) (clinicaltrials.gov) - Nov 28, 2012
P=N/A, N=117, Completed, Sponsor: University of Rochester
Active, not recruiting --> Completed Recruiting --> Completed

|||||||||| Trial initiation date: CHANGE -it is About Life (clinicaltrials.gov) - Nov 26, 2012
P3, N=450, Not yet recruiting, Sponsor: Mental Health Services in the Capital Region, Denmark
Recruiting --> Completed Initiation date: Aug 2012 --> Dec 2012

||||||||||  flutamide / Generic mfg.
Enrollment change:  Metabolic Syndrome in PCOS: Precursors and Interventions (clinicaltrials.gov) -  Nov 4, 2012
P=N/A, N=97, Completed,  Sponsor: Northwestern University
Initiation date: Aug 2012 --> Dec 2012 N=200 --> 97

||||||||||  flutamide / Generic mfg.
Trial completion:  Metabolic Syndrome in PCOS: Precursors and Interventions (clinicaltrials.gov) -  Nov 4, 2012
P=N/A, N=97, Completed,  Sponsor: Northwestern University
N=200 --> 97 Active, not recruiting --> Completed

|||||||||| Trial termination: Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features (clinicaltrials.gov) - Nov 1, 2012
P=N/A, N=14, Terminated, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Recruiting --> Terminated; PI left Massachusetts General Hospital Inpatient service

|||||||||| Enrollment change: Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features (clinicaltrials.gov) - Nov 1, 2012
P=N/A, N=14, Terminated, Sponsor: Massachusetts General Hospital
Recruiting --> Terminated; PI left Massachusetts General Hospital Inpatient service N=60 --> 14

|||||||||| Trial completion: The Role of Leptin Receptors in NASH (clinicaltrials.gov) - Oct 31, 2012
P=N/A, N=104, Completed, Sponsor: University of California, Davis
N=60 --> 14 Recruiting --> Completed

|||||||||| Enrollment open: Garlic4: Effect of Aged Garlic Extract on Atherosclerosis (clinicaltrials.gov) - Oct 25, 2012
P4, N=65, Recruiting, Sponsor: Los Angeles Biomedical Research Institute
Recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Enrollment change: CCRC: Effects of Partially Hydrolyzed Whey Peptides (PHWP) On Weight Loss In Individuals With The Metabolic Syndrome (METS) (clinicaltrials.gov) - Oct 24, 2012
P=N/A, N=35, Completed, Sponsor: Sidika E. Karakas, MD
Not yet recruiting --> Recruiting N=80 --> 35

|||||||||| Trial completion: CCRC: Effects of Partially Hydrolyzed Whey Peptides (PHWP) On Weight Loss In Individuals With The Metabolic Syndrome (METS) (clinicaltrials.gov) - Oct 24, 2012
P=N/A, N=35, Completed, Sponsor: Sidika E. Karakas, MD
N=80 --> 35 Not yet recruiting --> Completed

||||||||||  aripiprazole / Generic mfg., ziprasidone / Generic mfg.
New P4 trial:  Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome (clinicaltrials.gov) -  Oct 23, 2012
P4, N=175, Completed,  Sponsor: University of Malaya

|||||||||| New P2 trial: Resveratrol and the Metabolic Syndrome (clinicaltrials.gov) - Oct 23, 2012
P2, N=30, Recruiting, Sponsor: Rockefeller University

|||||||||| Enrollment change: Effect of Testosterone Replacement on Insulin Resistance (clinicaltrials.gov) - Oct 21, 2012
P4, N=19, Completed, Sponsor: McGuire Research Institute
Not yet recruiting --> Completed N=24 --> 19

|||||||||| Trial completion: Xanthohumol and Metabolic Syndrome (clinicaltrials.gov) - Oct 17, 2012
P=N/A, N=48, Completed, Sponsor: Oregon State University
N=24 --> 19 Recruiting --> Completed

|||||||||| Enrollment open: Body Weight and Vascular Function (clinicaltrials.gov) - Oct 10, 2012
P=N/A, N=75, Recruiting, Sponsor: Maastricht University Medical Center
Recruiting --> Completed Not yet recruiting --> Recruiting

||||||||||  Daliresp (roflumilast) / AstraZeneca, Takeda, AbbVie
New P2 trial:  RAMBO: Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) -  Oct 3, 2012
P2, N=122, Recruiting,  Sponsor: Laval University

||||||||||  rosiglitazone / Generic mfg.
Trial completion:  Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome (clinicaltrials.gov) -  Oct 3, 2012
P4, N=0, Completed,  Sponsor: University of Colorado, Denver
Not yet recruiting --> Recruiting Active, not recruiting --> Completed

|||||||||| New P1 trial: KWG: Acute Dose Response of Korean White Ginseng in Metabolic Syndrome or Type 2 Diabetes (clinicaltrials.gov) - Oct 1, 2012
P1, N=30, Completed, Sponsor: St. Michael's Hospital, Toronto

|||||||||| Biomarker: CAR-191: The BANGALORE Study; Combination of Berberine, Lipoic Acid, and Picrorhiza (clinicaltrials.gov) - Sep 27, 2012
P=N/A, N=50, Recruiting, Sponsor: Carmel Biosciences

|||||||||| Trial completion: Dose Ranging Study of the Effects of Alpha Lipoic Acid on Oxidative Stress (clinicaltrials.gov) - Sep 26, 2012
P2, N=77, Completed, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed Recruiting --> Completed

||||||||||  atorvastatin / Generic mfg.
Enrollment change:  Effect of a Fibrate and a Statin on Endothelial Dysfunction (clinicaltrials.gov) -  Sep 23, 2012
P=N/A, N=28, Terminated,  Sponsor: Boston University
Recruiting --> Completed N=19 --> 28

|||||||||| Enrollment open: Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia (clinicaltrials.gov) - Sep 21, 2012
P=N/A, N=80, Recruiting, Sponsor: Chiang Mai University
N=19 --> 28 Active, not recruiting --> Recruiting

|||||||||| Enrollment change: Effect of Genistein in Women With Metabolic Syndrome (clinicaltrials.gov) - Sep 12, 2012
P2/3, N=120, Completed, Sponsor: University of Messina
Active, not recruiting --> Recruiting N=180 --> 120

||||||||||  metformin / Generic mfg.
Enrollment change:  Lifestyle Modification and Metformin Use in the Treatment of HIV (clinicaltrials.gov) -  Sep 12, 2012
P=N/A, N=50, Completed,  Sponsor: Massachusetts General Hospital
N=180 --> 120 N=200 --> 50

|||||||||| Trial completion: Effect of Genistein in Women With Metabolic Syndrome (clinicaltrials.gov) - Sep 12, 2012
P2/3, N=120, Completed, Sponsor: University of Messina
N=200 --> 50 Recruiting --> Completed

||||||||||  metformin / Generic mfg.
Trial completion:  Lifestyle Modification and Metformin Use in the Treatment of HIV (clinicaltrials.gov) -  Sep 12, 2012
P=N/A, N=50, Completed,  Sponsor: Massachusetts General Hospital
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: E-LITE: Evaluation of Lifestyle Interventions to Treat Elevated Cardiometabolic Risk in Primary Care (clinicaltrials.gov) - Sep 10, 2012
P2, N=241, Completed, Sponsor: Palo Alto Medical Foundation
Active, not recruiting --> Completed Recruiting --> Completed

|||||||||| New P2 trial: Oral Nitrite in Adults With Metabolic Syndrome and Hypertension (clinicaltrials.gov) - Sep 6, 2012
P2, N=20, Recruiting, Sponsor: University of Pittsburgh

|||||||||| Clinical: OPTIFIT-Optimal Fiber Trial for Diabetes Prevention (clinicaltrials.gov) - Sep 5, 2012
P=N/A, N=200, Recruiting, Sponsor: German Institute of Human Nutrition

|||||||||| Enrollment closed: A Simple Dietary Message to Improve Dietary Quality for Metabolic Syndrome (clinicaltrials.gov) - Aug 27, 2012
P=N/A, N=240, Active, not recruiting, Sponsor: University of Massachusetts, Worcester
Recruiting --> Completed Recruiting --> Active, not recruiting

|||||||||| Enrollment closed: Effect of an Iridoid Enriched Beverage on Skin Autofluorescence (clinicaltrials.gov) - Aug 23, 2012
P1, N=48, Active, not recruiting, Sponsor: Tahitian Noni International, Inc.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting

|||||||||| Clinical: Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up (clinicaltrials.gov) - Aug 15, 2012
P=N/A, N=1450, Recruiting, Sponsor: University Hospital, Essen

|||||||||| Trial completion: The Effect of the Treatment Program "Dr. Fedon Lindbergs Vektcoach" on Body Weight and Composition and Hormonal Profile (clinicaltrials.gov) - Aug 13, 2012
P=N/A, N=44, Completed, Sponsor: Eurodiet Scandinavia AS
Recruiting --> Active, not recruiting Active, not recruiting --> Completed

|||||||||| New P2/3 trial: Effects of Genistein in Postmenopausal Women With Metabolic Syndrome (clinicaltrials.gov) - Aug 12, 2012
P2/3, N=120, Completed, Sponsor: University of Messina

|||||||||| Trial completion: Effect of Fish Oil on Insulin Sensitivity (clinicaltrials.gov) - Aug 5, 2012
P=N/A, N=34, Completed, Sponsor: University of Aberdeen
Active, not recruiting --> Completed Active, not recruiting --> Completed